Sex and APOE ε4 allele dose relate to longitudinal brain aging by amyloid status
- 1McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University
Abstract
INTRODUCTIONSex and APOE {varepsilon}4 influence Alzheimers disease risk, but whether they are associated with longitudinal structural brain aging and whether these associations depend on amyloid status is unclear. We tested these relationships using brain age gap (BAG), an MRI-derived marker of age-disproportionate brain atrophy.
METHODSWe trained a deep-learning brain-age model on 26,512 neurologically healthy UK Biobank participants and adapted it in 3,332 amyloid-negative cognitively normal MCSA and OASIS-3 scans. Without ADNI training, the model was applied to 4,399 T1-weighted MRI visits from 1,337 ADNI participants. Linear mixed-effects and survival models tested associations among sex, APOE {varepsilon}4 allele dose, amyloid status, BAG, cognition, atrophy, and amyloid conversion; equivalence tests evaluated null effects.
RESULTSAmong amyloid-positive participants, women and men had similar baseline BAG, but BAG increased faster in women. APOE {varepsilon}4 was associated with faster BAG increase in a dose-dependent manner. Higher and increasing BAG tracked hippocampal, fusiform, and whole-brain tissue loss in both amyloid groups. In amyloid-negative participants, BAG change was unrelated to four of five cognitive measures, with effects equivalent to zero within {+/-}0.1 SD, whereas within-person BAG-cognition associations were evident across all five measures in amyloid-positive participants. Higher baseline BAG predicted progression from MCI to dementia (HR 1.67) and from cognitively normal to impaired (HR 1.40).
DISCUSSIONSex and APOE {varepsilon}4 allele dose were associated with longitudinal brain aging primarily among amyloid-positive participants. BAG tracked structural neurodegeneration and showed stronger cognitive associations among amyloid-positive participants, supporting its interpretation as a stage-dependent marker of Alzheimer-related neurodegeneration. Independent replication is needed.
Related
- Amyloid and Tau Neuropathologic Stage, Coexisting Brain Disease, and Cognitive Status in a Population-Based Autopsy Cohort
- Longitudinal amyloid-beta measurements and blood–brain barrier dysfunction in cerebral amyloid angiopathy as part of the Mechanisms Of DEMentia project: protocol of the MODEM-LAMBDA-C study
- Multimodal neuroimaging and electrophysiological signatures in amnestic mild cognitive impairment with different amyloid-β deposition status: correlations with cognitive function and diagnostic value
- Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay
- Associations of longitudinal blood pressure with cerebral amyloid angiopathy in older adults
BibTeX
@misc{rajabli2026apoe,
title = {{Sex and APOE ε4 allele dose relate to longitudinal brain aging by amyloid status}},
author = {R. Rajabli and M. Soltaninejad and S. Villeneuve and D. L. Collins},
howpublished = {medRxiv},
year = {2026},
month = jul,
doi = {10.64898/2026.07.13.26357678},
url = {https://www.medrxiv.org/content/10.64898/2026.07.13.26357678v2},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Sex and APOE ε4 allele dose relate to longitudinal brain aging by amyloid status
AU - R. Rajabli
AU - M. Soltaninejad
AU - S. Villeneuve
AU - D. L. Collins
PY - 2026
DA - 2026/07/13
PB - medRxiv
DO - 10.64898/2026.07.13.26357678
UR - https://www.medrxiv.org/content/10.64898/2026.07.13.26357678v2
AB - INTRODUCTIONSex and APOE {varepsilon}4 influence Alzheimers disease risk, but whether they are associated with longitudinal structural brain aging and whether these associations depend on amyloid status is unclear. We tested these relationships using brain age gap (BAG), an MRI-derived marker of age-disproportionate brain atrophy. METHODSWe trained a deep-learning brain-age model on 26,512 neurologically healthy UK Biobank participants and adapted it in 3,332 amyloid-negative cognitively normal MCSA and OASIS-3 scans. Without ADNI training, the model was applied to 4,399 T1-weighted MRI visits from 1,337 ADNI participants. Linear mixed-effects and survival models tested associations among sex, APOE {varepsilon}4 allele dose, amyloid status, BAG, cognition, atrophy, and amyloid conversion; equivalence tests evaluated null effects. RESULTSAmong amyloid-positive participants, women and men had similar baseline BAG, but BAG increased faster in women. APOE {varepsilon}4 was associated with faster BAG increase in a dose-dependent manner. Higher and increasing BAG tracked hippocampal, fusiform, and whole-brain tissue loss in both amyloid groups. In amyloid-negative participants, BAG change was unrelated to four of five cognitive measures, with effects equivalent to zero within {+/-}0.1 SD, whereas within-person BAG-cognition associations were evident across all five measures in amyloid-positive participants. Higher baseline BAG predicted progression from MCI to dementia (HR 1.67) and from cognitively normal to impaired (HR 1.40). DISCUSSIONSex and APOE {varepsilon}4 allele dose were associated with longitudinal brain aging primarily among amyloid-positive participants. BAG tracked structural neurodegeneration and showed stronger cognitive associations among amyloid-positive participants, supporting its interpretation as a stage-dependent marker of Alzheimer-related neurodegeneration. Independent replication is needed.
ER -